The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
NMDA antagonists potentiate antiparkinsonian actions of L‐dopa in monoamine‐depleted rats
Abstract
Systemically administered N‐methyl‐D‐aspartate (NMDA) antagonists, MK‐801((+)5‐methyl‐10,11‐dihydro‐5H‐dibenzo(a, d)cyclohepten‐5,10‐imine maleate) and CPP(3‐[(±)‐2‐carboxypiperazin‐4‐y1]‐propyl‐1‐phosphonate), potentiate the ability of L‐dopa (L‐3,4‐dihydroxyphenylalanine) to reverse akinesia and to alleviate muscular rigidity in monoamine‐depleted rats. On the basis of these findings, it is proposed that NMDA antagonists may be beneficial as adjunctive treatment in the therapy of Parkinson's disease. CPP locally injected into the subthalamic nucleus, entopeduncular nucleus–the rat homologue of the internal pallidal segment–or substantia nigra pars reticulata of monoamine‐depleted rats stimulates locomotor activity and alleviates rigidity, whereas local microinjection of CPP into the neostriatum is ineffective. These results make it unlikely that the neostriatum is the site of the antiparkinsonian action of NMDA antagonists in monoamine‐depleted rats, whereas the subthalamic nucleus, internal pallidal segment, and substantia nigra pars reticulata appear to be important for the effects of NMDA antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
Clineschmidt, B. V., Martin, G. E., & Bunting, P. R. (1982) · Drug Development Research · doi:10.1002/ddr.430020203 · Cited by 498
Role for Excitatory Amino Acids in Methamphetamine-Induced Nigrostriatal Dopaminergic Toxicity
Sonsalla, P. K., Nicklas, W. J., & Heikkila, R. E. (1989) · Science · doi:10.1126/science.2563176 · Cited by 490
Mitchell, I. J., Clarke, C. E., Boyce, S., Robertson, R. G., Peggs, D., Sambrook, M. A., & Crossman, A. R. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90120-6 · Cited by 460
Herlofson, K., & Larsen, J. P. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.02033.x · Cited by 441
Tricklebank, M. D., Singh, L., Oles, R. J., Preston, C., & Iversen, S. D. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90754-1 · Cited by 433
Excitatory amino acid transmission: Neurology and neurobiology, volume 24
Hicks, T. P., Lodge, D., McClennan, H., Hardy, J. A., & Cowburn, R. F. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80857-8 · Cited by 432
The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
Carlsson, M., & Carlsson, A. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258633 · Cited by 423
Miller, W. C., & DeLong, M. R. (1987) · Advances in Behavioral Biology · doi:10.1007/978-1-4684-5347-8_29 · Cited by 418
Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity
Smith, Y., & Parent, A. (1988) · Brain Research · doi:10.1016/0006-8993(88)90177-1 · Cited by 331
Koek, W., Woods, J. H., & Winger, G. D. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24082-4 · Cited by 305
Snyder, S. H., & D'Amato, R. J. (1986) · Neurology · doi:10.1212/wnl.36.2.250 · Cited by 294
Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex
Kornhuber, J., Bormann, J., Retz, W., Hübers, M., & Riederer, P. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90384-1 · Cited by 253
Clineschmidt, B. V., Martin, G. E., Bunting, P. R., & Papp, N. L. (1982) · Drug Development Research · doi:10.1002/ddr.430020204 · Cited by 230
Anatomy and Physiology of the Subthalamic Nucleus: A Driving Force of the Basal Ganglia
Kitai, S. T., & Kita, H. (1987) · Advances in Behavioral Biology · doi:10.1007/978-1-4684-5347-8_25 · Cited by 202
Thi�bot, M.-H., Kloczko, J., Chermat, R., Soubri�, P., Puech, A. J., & Simon, P. (1982) · Drug Development Research · doi:10.1002/ddr.430010718 · Cited by 193
Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease
Klockgether, T., & Turski, L. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90007-6 · Cited by 186
Self-citationCarlsson, M., & Carlsson, A. (1989) · Journal of Neural Transmission · doi:10.1007/bf01255820 · Cited by 174
Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats
Schmidt, W. J., & Bubser, M. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90007-5 · Cited by 165
Pan, H. S., Penney, J. B., & Young, A. B. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07205.x · Cited by 158
EFFERENT MUSCLE INNERVATION AND RIGIDITY.
Steg, G. (1964) · PubMed · Cited by 151
Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists
Olney, J. W., Price, M. T., Labruyere, J., Salles, K. S., Frierdich, G. E., Mueller, M., & Silverman, E. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90123-3 · Cited by 114
Muscle relaxant action of excitatory amino acid antagonists
Turski, L., Schwarz, M., Turski, W. A., Klockgether, T., Sontag, K. ‐., & Collins, J. F. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90558-0 · Cited by 101
Self-citationRouzaire-Dubois, B., & Scarnati, E. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90133-3 · Cited by 94
Efferent muscle innervation and rigidity
Steg, G. (1964) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 87
Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey
Crossman, A. R., Peggs, D., Boyce, S., Luquin, M. R., & Sambrook, M. A. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90221-9 · Cited by 76
Klockgether, T., Schwarz, M., Turski, L., Wolfarth, S., & Sontag, K. ‐. (1985) · Experimental Brain Research · doi:10.1007/bf00235872 · Cited by 37
Self-citationγ‐Aminobutyric Acid and Basal Ganglia Outflow Pathways
Reavill, C. A., Jenner, P. G., & MARSDEN, C. D. (1984) · Novartis Foundation symposium · doi:10.1002/9780470720882.ch9 · Cited by 12
Cited by
Circuit Mechanisms of Parkinson’s Disease
McGregor, M. M., & Nelson, A. B. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.004 · Cited by 624
Functional changes of the basal ganglia circuitry in Parkinson's disease
Blandini, F., Nappi, G., Tassorelli, C., & Martignoni, E. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00067-2 · Cited by 582
Dopamine receptors: Molecular biology, biochemistry and behavioural aspects
Jackson, D. M., & Westlind-Danielsson, A. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90041-8 · Cited by 483
Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions
Di Chiara, G., Morelli, M., & Consolo, S. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90005-1 · Cited by 467
Dunah, A. W., & Standaert, D. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05546.2001 · Cited by 373
Metadata
- Authors
- Klockgether, T., & Turski, L.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1990-10
- Volume
- 28
- Issue
- 4
- Pages
- 539-546
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1999649044
- Cited by
- 284
- References
- 32
- FWCI
- 17.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.